Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/5bf55b54-34b9-471d-8d56-1c747e82e37b/

YATHARTH

Yatharth Hospital & Trauma Care Services Limited
Chart
₹808.90
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.41
OS Score
13.0%
Value
65.0%
Quality
93.0%
Momentum
6/9
F-Score
0.291
QV
Strategy Eligibility
3 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
Noneyr
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
12-1 60%
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
RAM 1.46
V
Value Analysis
Cheapness relative to fundamentals
13.0%ile
P/E
44.2×
P/S
6.5×
P/B
4.4×
E/P
0.0226
FCF Yield
-0.014
EBITDA/EV
0.040
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
86.00000000
/100 — 1=cheapest
VC2 (Trending Value)
88.00000000
/100
VC3 (Buyback)
88.00000000
/100
P/E of 44.2x is premium-priced — the market is paying up for expected growth. Negative FCF yield (-1.4%) — the business is currently cash-consumptive. VC2 score of 88.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
65.0%ile
ROE
0.099
ROA
0.077
Net Margin
0.147
Op Margin
0.163
GPA
0.392
Current
3.87
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.363
Earn Growth
0.343
Stability
0.081
lower=better
Accruals
-0.012
lower=better
5yr Consist
Yes
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
93.0%ile
6M Return
17.8%
12M Return
49.9%
12-1 Mom
59.7%
Risk-Adj
1.46
Vol 252d
40.8%
Vol 60d
91.7%
↑ Expanding
Max DD 12M
-32.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 60% is very strong — a clear uptrend. Near-term vol (92%) is expanding vs long-term (41%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.41
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 160 peers
Sector Value %ile
28.0%
Sector Quality %ile
46.0%
P/E z-score
-0.14
P/B z-score
-0.24
Sector Avg OS
43.7%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
NATCOPHARM NATCO Pharma Limited 98.0% 88.0% 87.0% 81.0%
UNIVPHOTO Universus Photo Imagings Limited 97.0% 86.0% 74.0% 94.0%
LINCOLN Lincoln Pharmaceuticals Limited 97.0% 88.0% 80.0% 81.0%
VENUSREM Venus Remedies Limited 96.0% 68.0% 94.0% 99.0%
STAR Strides Pharma Science Limited 96.0% 73.0% 91.0% 91.0%
HALEOSLABS Haleos Labs Limited 95.0% 82.0% 77.0% 81.0%
AUROPHARMA Aurobindo Pharma Limited 94.0% 71.0% 84.0% 87.0%
SPARC Sun Pharma Advanced Research Company Limited 93.0% 72.0% 86.0% 83.0%
Factor Interactions
Hot but Volatile
Strong momentum (93th) but high volatility (41%). Momentum could reverse sharply.
Volatility Expanding
60-day vol (92%) significantly exceeds 252-day (41%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
24.2% avg (7 factors)
Quality
B
62.4% avg (7 factors)
Momentum
A
77.5% avg (4 factors)
Risk
C
48.6% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.410—0
Value %ile0.130—1
Quality %ile0.650—0
Momentum %ile0.930—1
F-Score6.000—0
Confidence0.939—1
Volatility0.408—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
44.25
Earnings Yield (E/P)
0.0226
Price / Sales
6.50
Price / Book
4.38
Price / Cash Flow
38.11
FCF Yield
-1.4%
EBITDA / EV
4.0%
Sales Yield (1/P·S)
0.1530
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
9.9%
Return on Assets
7.7%
Net Margin
14.7%
Operating Margin
16.3%
Gross Profit / Assets
Novy-Marx GPA
39.2%
Current Ratio
3.87
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.012
MomentumPrice trend strength over different horizons
6M Return
17.8%
12M Return
49.9%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
59.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.46
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
36.3%
Earnings Growth (YoY)
34.3%
Earnings Stability (CV)
Lower = more stable
0.081
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
6
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
86
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
88
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
88
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity